Early feeding practices key to shaping lifelong oral microbiome

Research delves into the little-explored world of the infant oral microbiome, examining how early nutrition and environmental factors shape it. With implications for lifelong health, the research aims to guide future health recommendations, emphasizing the need for more longitudinal studies and advanced sequencing techniques.

Formycon announces EMA submission for FYB203, a biosimilar candidate to Eylea® (Aflibercept) – Biotech Investments

EQS-News: Formycon AG / Key word(s): Regulatory Admission Formycon announces EMA submission for FYB203, a biosimilar candidate to Eylea® (Aflibercept) 27.11.2023 / 07:30 CET/CEST The

November 28, 2023

Equillium collaborates with Vivtex for oral formulation of autoimmune therapy – Pharmaceutical Technology

An oral EQ302 formulation could offer a convenient, bioavailable therapy for patients with inflammatory and autoimmune diseases. Image: Shutterstock/ Busra Ispir. Massachusetts-based biotech Vivtex and

September 17, 2024

Virginia governor vetoes bill to create advisory board to reduce drug prices

Virginia Gov. Glenn Youngkin vetoed legislation late Monday that would have established an advisory board to better manage the state’s prescription drug costs. Other states

April 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.